MetLife Investment Management’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $78.5K | Sell |
|
|||||
|
2025
Q2 | $98.4K | Sell |
|
|||||
|
2025
Q1 | $72.2K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $119K | Hold |
|
|||||
|
2024
Q2 | $149K | Buy |
|
|||||
|
2024
Q1 | $181K | Hold |
|
|||||
|
2023
Q4 | $97.3K | Hold |
|
|||||
|
2023
Q3 | $115K | Hold |
|
|||||
|
2023
Q2 | $221K | Hold |
|
|||||
|
2023
Q1 | $418K | Hold |
|
|||||
|
2022
Q4 | $481K | Hold |
|
|||||
|
2022
Q3 | $536K | Sell |
|
|||||
|
2022
Q2 | $518K | Hold |
|
|||||
|
2022
Q1 | $780K | Buy |
|
|||||
|
2021
Q4 | $510K | Hold |
|
|||||
|
2021
Q3 | $387K | Sell |
|
|||||
|
2021
Q2 | $365K | Hold |
|
|||||
|
2021
Q1 | $409K | Hold |
|
|||||
|
2020
Q4 | $349K | Hold |
|
|||||
|
2020
Q3 | $380K | Hold |
|
|||||
|
2020
Q2 | $416K | Hold |
|
|||||
|
2020
Q1 | $427K | Buy |
|
|||||
|
2019
Q4 | $469K | Hold |
|
|||||
|
2019
Q3 | $456K | Hold |
|
|||||
|
2019
Q2 | $641K | Hold |
|
|||||
|
2019
Q1 | $726K | Hold |
|
|||||
|
2018
Q4 | $538K | Hold |
|
|||||
|
2018
Q3 | $649K | Hold |
|
|||||
|
2018
Q2 | $881K | Hold |
|
|||||
|
2018
Q1 | $615K | Hold |
|
|||||
|
2017
Q4 | $446K | Buy |
|